Ofatumumab Reduces Clinical and Radiological Activity in People with Recently Diagnosed Treatment-Naive Relapsing Multiple Sclerosis Irrespective of Baseline Serum Neurofilament Light Chain Levels

Authors
Category Primary study
ConferenceMultiple Sclerosis Journal
Year 2024
This article has no abstract
Epistemonikos ID: b62e0191359d2bb97b48407fab1ec56cc0ffcad6
First added on: Apr 30, 2026